See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Donald Trump
Artificial Intelligence
Social Media
Natural Disasters
Inflation
Infrastructure
Facebook
Swimming
Republican Party
Coronavirus
Property
European Union
lifesciencesbc.ca image

News from lifesciencesbc.ca

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
AbbVie

AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma

57% Center coverage: 7 sources
AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile.See the Story
Lonza Launches Next Generation 4D-Nucleofector® LV Unit PRO for Improved Electroporation in GMP Manufacturing - Life Sciences British Columbia
British Columbia · British Columbia

Lonza Launches Next Generation 4D-Nucleofector® LV Unit PRO for Improved Electroporation in GMP Manufacturing - Life Sciences British Columbia

Lonza announced the launch of 4D-Nucleofector® LV Unit PRO, their next-generation large-scale electroporation unit.See the Story
Bio-economy employers to have access to new practical training to address workplace harassment - Life Sciences British Columbia
Vancouver, British Columbia · Vancouver

Bio-economy employers to have access to new practical training to address workplace harassment - Life Sciences British Columbia

OTTAWA, July 10, 2025 – Employers in Canada’s bio-economy will gain support with a new initiative addressing workplace sexual harassment. BioTalent Canada’s latest project, Building a safer bio-economy: Addressing sexual harassment in […]Read Article

Labcorp and NOWDx Collaborate to Expand Access to Rapid Syphilis Testing - Life Sciences British Columbia

Labcorp, a leader of laboratory services, announced a new initiative with NOWDiagnostics to expand access to rapid syphilis testing.Victoria, British Columbia · VictoriaRead Article

Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 mRNA-LNP Adjuvant - Life Sciences British Columbia

Acuitas announced the publication of new study, “An IL12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses.”Vancouver, British Columbia · VancouverRead Article

Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer - Life Sciences British Columbia

Abdera Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Rachael Brake as chief scientific officer.Vancouver, British Columbia · VancouverRead Article

Vertex Presents Longer-Term Data at the 2025 European Hematology Association (EHA) Congress Demonstrating Durability of CASGEVY® and Provides Update on Expanding Global Access to CASGEVY - Life Sciences British Columbia

Vertex Pharmaceuticals recently announced positive longer-term data for PrCASGEVY® (exagamglogene autotemcel).British Columbia · British ColumbiaRead Article

Quebec Implements Public Reimbursement of Pluvicto® – A Defining Milestone for Radioligand Therapy in Canada - Life Sciences British Columbia

Novartis Pharmaceuticals Canada Inc. is pleased to announce that, as of July 2, 2025, Pluvicto® is publicly reimbursed in Quebec.British Columbia · British ColumbiaRead Article

AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline

87% Center coverage: 8 sources
AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells. The University of Pennsylvania spinout’s lead program recently began a Phase 1 test as a potential treatment for B cell-mediated autoimmune disorders. The post AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline appeared first on MedCity News.CancerSee the Story

Dual PDE4/10 Inhibition Restores CREB1 Function and Enhances Neuronal Resilience in Alzheimer's Disease

Background Alzheimer’s disease (AD) involves cognitive decline, amyloid-beta (Aβ) accumulation, tau hyperphosphorylation, and neuroinflammation. CREB1, a key transcription factor for memory, is downregulated in AD, contributing to disease progression. MethodsAlzheimer's Disease · British ColumbiaSee the Story

UNBC President Dr. Geoff Payne to Join Michael Smith Health Research BC, Leaving UNBC

University of Northern British Columbia President and Vice-Chancellor Dr. Geoff Payne is taking on a new leadership role as President and CEO with Michael Smith Health Research BC and will be stepping down from his position at UNBC. While Payne’s collaborative and inclusive leadership style will serve him well in his new position, it has […]Vancouver, British Columbia · VancouverSee the Story

Breaking News Topics Related to lifesciencesbc.ca

British Columbia icon

British Columbia

Canada icon

Canada

Quebec icon

Quebec

Toronto, ON icon

Toronto, ON

Cancer icon

Cancer

Greater Vancouver icon

Greater Vancouver

Vancouver, British Columbia icon

Vancouver, British Columbia

Ontario, Canada icon

Ontario, Canada

United States icon

United States

News
For You
SearchBlindspotLocal